Gilead Says Drug Helped Moderately Ill Coronavirus Patients
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. |!| Reno
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. |!| Reno